Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
- First Posted Date
- 2008-10-16
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 57
- Registration Number
- NCT00773708
- Locations
- 🇪🇸
H.U. Germans Trias i Pujol, Badalona, Barcelona, Spain
Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2011-06-02
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT00753792
- Locations
- 🇪🇸
Hospital de Mataró, Barcelona, Spain
🇪🇸Hospital Clinic de Barcelona, Barcelona, Spain
🇪🇸Hospital Vall d'Hebron, Barcelona, Spain
Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
- Conditions
- HIV Infections
- Interventions
- Drug: Addition of raltegravir 800 mg QD to HAART
- First Posted Date
- 2008-07-18
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00718536
- Locations
- 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
- Conditions
- HIV Infections
- Interventions
- Drug: Salvage antiretroviral therapy including raltegravir
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00685191
- Locations
- 🇪🇸
Hospital U. Germans Trias i Pujol, Badalona, Barcelona, Spain
Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
- Conditions
- HIV Infections
- Interventions
- Behavioral: Lifestyle modifications
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Registration Number
- NCT00662077
- Locations
- 🇪🇸
Germans Trias i Pujol Hospital - Lluita Sida Foundation, Badalona, Barcelona, Spain
Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT00661349
- Locations
- 🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸Hospital Clínico de Salamanca, Salamanca, Spain
🇪🇸Hospital Universitario Príncipe de Asturias, Madrid, Spain
Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT00611039
- Locations
- 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
- Conditions
- HIV Infections
- Interventions
- Drug: tipranavir/ritonavir (dose reduction)
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT00607958
- Locations
- 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
- Conditions
- HIV Infections
- Interventions
- Drug: MK-0518 400mg twice a day
- First Posted Date
- 2007-11-06
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 69
- Registration Number
- NCT00554398
- Locations
- 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸Hospital Clínic I Provinical de Barcelona, Barcelona, Spain
Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+
- First Posted Date
- 2007-11-02
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT00552682
- Locations
- 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain